Injectable slow-release therapy reverses osteoarthritis in animal tests
TL;DR
UC Boulder researchers have developed a slow-release injectable therapy that prompts joint cells to repair cartilage and bone, reversing osteoarthritis in animal models within weeks. They’ve completed the first phase of experiments and are moving to safety/toxicity studies to enable human trials—potentially within 18 months—funded by ARPA-H’s NITRO program, as they pursue options beyond pain management and joint replacement.
Topics:businessscience#cartilage#clinical-trials#drug-delivery#osteoarthritis#regenerative-medicine#science
- Experimental Drug Can Reverse Osteoarthritis in Weeks, Animal Research Shows ScienceAlert
- Stunning Stanford study finds way to regrow joint cartilage. Could it mean an end to osteoarthritis? KTVU
- Scientists test new ways to regrow joints damaged by arthritis Medical Xpress
- New Research Brings Joint Repair Closer for Millions With Osteoarthritis Duke Health
- Federal Agency Unveils Three Potential Osteoarthritis Treatments The New York Times
Want the full story? Read the original reporting
Read on ScienceAlert